Invasive Management After Myocardial Infarction

Log in or subscribe to view full content.
Article is also available for purchase the article in one of the available formats.

Table of Contents

Hospital Practice:

Volume 28 No. 5



Purchase this article in one of the formats specified below:

DOI: 10.3810/hp.1993.05.894
Abstract: Recent data establishing the benefit of thrombolytic therapy for acute myocardial infarction leave many questions unanswered. Among them are crucial dilemmas regarding invasive management. For patients who receive thrombolytic therapy in the emergency room, what is the proper role of catheterization and percutaneous transluminal coronary angioplasty (PTCA)? Should the procedures be used routinely or only when indicated by particular clinical circumstances? And what about patients for whom thrombolytic therapy is contraindicated?